Detalhe da pesquisa
1.
VSIG4-expressing tumor-associated macrophages impair anti-tumor immunity.
Biochem Biophys Res Commun
; 628: 18-24, 2022 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36063598
2.
Expression of VISTA on tumor-infiltrating immune cells correlated with short intravesical recurrence in non-muscle-invasive bladder cancer.
Cancer Immunol Immunother
; 70(11): 3113-3122, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33770210
3.
Immunoregulatory protein V-set and immunoglobulin domain-containing 4 is overexpressed in patients with endometriosis.
J Obstet Gynaecol Res
; 47(1): 119-127, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32830403
4.
Placental Pathologic Changes Associated with Fetal Growth Restriction and Consequent Neonatal Outcomes.
Fetal Pediatr Pathol
; 40(5): 430-441, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32056478
5.
Prognostic factors of oncologic outcomes after fertility-preservative management with progestin in early-stage of endometrial cancer.
J Res Med Sci
; 26: 48, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34484380
6.
The association between expression of p53 and aggressiveness of serous adenocarcinoma of the uterine cervix.
J Res Med Sci
; 25: 47, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32765617
7.
Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041).
Gynecol Oncol
; 152(1): 61-67, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30409490
8.
Arsenic trioxide and tetraarsenic oxide induce cytotoxicity and have a synergistic effect with cisplatin in paclitaxel-resistant ovarian cancer cells.
Acta Oncol
; 58(11): 1594-1602, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31257975
9.
Clinical significance of the pattern-based classification in endocervical adenocarcinoma, usual and variants.
Int J Clin Oncol
; 24(10): 1264-1272, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31140099
10.
Thrombosed Fetal Dural Sinus Malformation: Correlation Between Prenatal Ultrasound and Autopsy Findings.
Fetal Pediatr Pathol
; 37(4): 287-295, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30265815
11.
Cervical Adenocarcinoma Has a Poorer Prognosis and a Higher Propensity for Distant Recurrence Than Squamous Cell Carcinoma.
Int J Gynecol Cancer
; 27(6): 1228-1236, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28604449
12.
The Significance of VSIG4 Expression in Ovarian Cancer.
Int J Gynecol Cancer
; 27(5): 872-878, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28498255
13.
Multifocal Kaposiform Hemangioendothelioma Causing Massive Fetal Chylous Ascites.
Fetal Pediatr Pathol
; 36(2): 162-167, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27983885
14.
Menopausal status induces vaginal dysbiosis in women with human papillomavirus infection.
Sci Rep
; 14(1): 7092, 2024 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38528061
15.
Comparison of survival outcome of open, total laparoscopic, and laparoscopy-assisted radical vaginal hysterectomy for stage IB2 cervical cancer patients: A multicenter retrospective study.
Medicine (Baltimore)
; 103(10): e37426, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38457577
16.
Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial).
J Gynecol Oncol
; 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330380
17.
Three-dimensional transvaginal ultrasonography for locally advanced cervical cancer.
Int J Gynecol Cancer
; 23(8): 1459-64, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24257560
18.
Risk Factors and Pregnancy Outcomes of Antepartum Hemorrhage in Women with Placenta Previa.
Reprod Sci
; 30(9): 2728-2735, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36940086
19.
Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer.
Taiwan J Obstet Gynecol
; 62(1): 107-111, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36720520
20.
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial.
J Gynecol Oncol
; 33(2): e12, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910393